tiprankstipranks
Gracell Biotechnologies (GRCL)
NASDAQ:GRCL
US Market

Gracell Biotechnologies (GRCL) Income Statement

134 Followers

Gracell Biotechnologies Income Statement

Last quarter (Q4 2022), Gracell Biotechnologies's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Gracell Biotechnologies's net income was $―. See Gracell Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
---$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 475.33M$ 90.57M$ 72.75M$ 214.40M$ 146.58M$ 62.50M
Operating Income
$ -475.33M$ -90.57M$ -72.75M$ -214.40M$ -146.58M$ -62.50M
Net Non Operating Interest Income Expense
$ 3.83M$ 2.49M$ 636.00K$ 715.00K$ 3.93M$ 1.44M
Other Income Expense
$ -5.32M$ -1.18M$ -1.42M$ 1.78M$ 3.98M$ 276.00K
Pretax Income
$ -476.81M$ -88.08M$ -70.89M$ -211.90M$ -138.66M$ -60.79M
Tax Provision
-$ 3.00K-$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -476.81M$ -88.08M$ -71.20M$ -274.63M$ -200.86M$ -72.99M
Basic EPS
$ -7.05$ -0.26$ -0.22$ -4.19$ -3.75$ -3.68
Diluted EPS
$ -7.05$ -0.26$ -0.22$ -4.19$ -3.75$ -3.68
Basic Average Shares
$ 202.98M$ 338.34M$ 328.87M$ 65.56M$ 36.97M$ 19.81M
Diluted Average Shares
$ 202.98M$ 338.34M$ 328.87M$ 65.56M$ 36.97M$ 19.81M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 475.33M$ 90.57M$ 72.75M$ 214.40M$ 146.58M$ 62.50M
Net Income From Continuing And Discontinued Operation
$ -476.81M$ -88.08M$ -70.89M$ -211.90M$ -138.66M$ -60.79M
Normalized Income
$ -467.33M--$ -208.99M$ -141.22M$ -60.79M
Interest Expense
$ 4.95M--$ 2.15M$ 0.00$ 0.00
EBIT
$ -471.87M$ -87.10M$ -71.53M$ -209.75M$ -138.66M$ -60.79M
EBITDA
$ -471.87M$ -78.58M$ -64.49M$ -188.16M$ -133.54M$ -57.80M
Currency in USD

Gracell Biotechnologies Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis